BACKGROUND: Right ventricular failure (RVF) in pulmonary hypertension (PH) is associated with increased incidence of sudden death by a poorly explored mechanism. We test the hypothesis that PH promotes spontaneous ventricular fibrillation (VF) during a critical post-PH onset period characterized by a sudden increase in mortality. METHODS AND RESULTS: Rats received either a single subcutaneous dose of monocrotaline (MCT, 60 mg/kg) to induce PH-associated RVF (PH, n=24) or saline (control, n=17). Activation pattern of the RV-epicardial surface was mapped using voltage-sensitive dye in isolated Langendorff-perfused hearts along with single glass-microelectrode and ECG-recordings. MCT-injected rats developed severe PH by day 21 and progressed to RVF by approximately day 30. Rats manifested increased mortality, and ≈30% rats died suddenly and precipitously during 23-32 days after MCT. This fatal period was associated with the initiation of spontaneous VF by a focal mechanism in the RV, which was subsequently maintained by both focal and incomplete reentrant wave fronts. Microelectrode recordings from the RV-epicardium at the onset of focal activity showed early afterdepolarization-mediated triggered activity that led to VF. The onset of the RV cellular triggered beats preceded left ventricular depolarizations by 23±8 ms. The RV but not the left ventricular cardiomyocytes isolated during this fatal period manifested significant action potential duration prolongation, dispersion, and an increased susceptibility to depolarization-induced repetitive activity. No spontaneous VF was observed in any of the control hearts. RVF was associated with significantly reduced RV ejection fraction (P<0.001), RV hypertrophy (P<0.001), and RV fibrosis (P<0.01). The hemodynamic function of the LV and its structure were preserved. CONCLUSIONS: PH-induced RVF is associated with a distinct phase of increased mortality characterized by spontaneous VF arising from the RV by an early afterdepolarization-mediated triggered activity.
BACKGROUND:Right ventricular failure (RVF) in pulmonary hypertension (PH) is associated with increased incidence of sudden death by a poorly explored mechanism. We test the hypothesis that PH promotes spontaneous ventricular fibrillation (VF) during a critical post-PH onset period characterized by a sudden increase in mortality. METHODS AND RESULTS:Rats received either a single subcutaneous dose of monocrotaline (MCT, 60 mg/kg) to induce PH-associated RVF (PH, n=24) or saline (control, n=17). Activation pattern of the RV-epicardial surface was mapped using voltage-sensitive dye in isolated Langendorff-perfused hearts along with single glass-microelectrode and ECG-recordings. MCT-injected rats developed severe PH by day 21 and progressed to RVF by approximately day 30. Rats manifested increased mortality, and ≈30% rats died suddenly and precipitously during 23-32 days after MCT. This fatal period was associated with the initiation of spontaneous VF by a focal mechanism in the RV, which was subsequently maintained by both focal and incomplete reentrant wave fronts. Microelectrode recordings from the RV-epicardium at the onset of focal activity showed early afterdepolarization-mediated triggered activity that led to VF. The onset of the RV cellular triggered beats preceded left ventricular depolarizations by 23±8 ms. The RV but not the left ventricular cardiomyocytes isolated during this fatal period manifested significant action potential duration prolongation, dispersion, and an increased susceptibility to depolarization-induced repetitive activity. No spontaneous VF was observed in any of the control hearts. RVF was associated with significantly reduced RV ejection fraction (P<0.001), RV hypertrophy (P<0.001), and RV fibrosis (P<0.01). The hemodynamic function of the LV and its structure were preserved. CONCLUSIONS: PH-induced RVF is associated with a distinct phase of increased mortality characterized by spontaneous VF arising from the RV by an early afterdepolarization-mediated triggered activity.
Authors: Stuart Rich; Jennifer Pogoriler; Aliya N Husain; Peter T Toth; Mardi Gomberg-Maitland; Stephen L Archer Journal: Chest Date: 2010-11 Impact factor: 9.410
Authors: Marius M Hoeper; Nazzareno Galié; Srinivas Murali; Horst Olschewski; Melvyn Rubenfire; Ivan M Robbins; Harrison W Farber; Vallerie McLaughlin; Shelley Shapiro; Joanna Pepke-Zaba; Joerg Winkler; Ralf Ewert; Christian Opitz; Volker Westerkamp; Jean-Luc Vachiéry; Adam Torbicki; Juergen Behr; Robyn J Barst Journal: Am J Respir Crit Care Med Date: 2002-02-01 Impact factor: 21.405
Authors: David Benoist; Rachel Stones; Mark Drinkhill; Olivier Bernus; Ed White Journal: Am J Physiol Heart Circ Physiol Date: 2011-03-11 Impact factor: 4.733
Authors: Benjamin Strauss; Yassine Sassi; Carlos Bueno-Beti; Zeki Ilkan; Nour Raad; Marine Cacheux; Malik Bisserier; Irene C Turnbull; Erik Kohlbrenner; Roger J Hajjar; Lahouaria Hadri; Fadi G Akar Journal: J Mol Cell Cardiol Date: 2018-11-28 Impact factor: 5.000
Authors: David Benoist; Rachel Stones; Mark J Drinkhill; Alan P Benson; Zhaokang Yang; Cecile Cassan; Stephen H Gilbert; David A Saint; Olivier Cazorla; Derek S Steele; Olivier Bernus; Ed White Journal: Am J Physiol Heart Circ Physiol Date: 2012-03-16 Impact factor: 4.733
Authors: Dirk Bandorski; D Erkapic; J Stempfl; R Höltgen; E Grünig; J Schmitt; R Chasan; J Grimminger; T Neumann; C W Hamm; W Seeger; H A Ghofrani; H Gall Journal: Herzschrittmacherther Elektrophysiol Date: 2015-06-02
Authors: Dirk L Ypey; Wilbert P M van Meerwijk; Soban Umar; Daniel A Pijnappels; Martin J Schalij; Arnoud van der Laarse Journal: Eur Biophys J Date: 2012-10-23 Impact factor: 1.733
Authors: Lian Tian; Danchen Wu; Asish Dasgupta; Kuang-Hueih Chen; Jeffrey Mewburn; Francois Potus; Patricia D A Lima; Zhigang Hong; Yuan-Yuan Zhao; Charles C T Hindmarch; Shelby Kutty; Steeve Provencher; Sebastien Bonnet; Gopinath Sutendra; Stephen L Archer Journal: Circ Res Date: 2020-03-27 Impact factor: 17.367